MedPath

A cohort study of haemodialysis patients based on hepatic magnetic resonance imaging

Not Applicable
Conditions
Chronic kidney disease
Urological and Genital Diseases
Chronic nephritic syndrome
Registration Number
ISRCTN80100088
Lead Sponsor
Quincy Association of Clinical Research and Therapeutics (non profit association, France)
Brief Summary

2012 Results article in https://www.ncbi.nlm.nih.gov/pubmed/22998881 results 2014 Results article in https://www.ncbi.nlm.nih.gov/pubmed/25506921 results 2015 Results article in https://www.ncbi.nlm.nih.gov/pubmed/26182077 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28124030 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28332280 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29270530 results 2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29340336 results 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30502056 results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33484427/ Calcific uremic arteriolopathy analysis in the total final 358 dialysis patients (added 13/09/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35890303/ Results (added 13/09/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped
Sex
All
Target Recruitment
411
Inclusion Criteria

1. Patients of either sex
2. Undergoing chronic intermittent bipuncture bicarbonate hemodialysis (with ultrapure dialysate single use biocompatible membranes) three times a week
Added 18/07/2013: 3. or peritoneal dialysis
Added 23/10/2018: 4. At initiation of dialysis and with longitudinal follow-up

Exclusion Criteria

1. Refusal to participate in the study
2. Poor compliance with the dialysis therapy schedule
3. Age < 18 years
4. Severe cognitive impairment
5. Claustrophobia
6. Hepatic cirrhosis
7. Overt inflammatory or infectious disease
8. Malnutrition
9. Recent major bleeding (< 3 months), major surgery (< 3 months), transfusion dependency, recent transfusion (< 3 months)
10. Intractable malignancy
11. Cardiac pacemakers and metallic cardiac valves

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath